Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial update on efficacy and safety of semaglutide injection in adults with Type 2 Diabetes.
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. [Phase 4]
Phase 4 trial comparing metformin produced by Pars Mino Co with Canadian Apotex Co in type 2 diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD [Phase 4]
Phase 4 trial evaluating the efficacy of empagliflozin and pioglitazone in patients with type 2 diabetes and non-alcoholic fatty liver disea…
-
FDA approval · 2023-07-10FDA Approved: XULTOPHY 100/3.6 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Xultophy 100/3.6, a fixed-ratio combination of insulin degludec and liraglutide, by Novo Nor…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes [Phase 3]
Phase 3 clinical trial investigating retagliptin phosphate combined with metformin for Type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial update of tirzepatide in Chinese participants with Type 2 diabetes mellitus has completed with results posted.
-
FDA approval · 2023-07-05FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKAMET, Janssen’s fixed-dose combination of canagliflozin and metformin hydrochloride.
-
FDA approval · 2023-07-05FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc., resulting in a labeling…
-
FDA approval · 2023-07-05FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVOKAMET XR (canagliflozin and metformin hydrochloride) submitted by Janssen Pharmaceuticals, I…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid [Phase 2]
A Phase 2 trial evaluated sex-related differences in arterial stiffness in type 2 diabetes patients with hyperuricemia, focusing on the role…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients [Phase 3]
A Phase 3 clinical trial comparing voglibose versus glibenclamide added to metformin for glycemic and cardiovascular outcomes in type 2 diab…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: A Study of LY3437943 in Participants With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial update for LY3437943 in participants with type 2 diabetes has completed with results posted.
-
FDA approval · 2023-06-29FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from sanofi-aventis U.S. LLC. This notice confirms regula…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia [Phase 4]
Phase 4 clinical trial comparing outpatient discharge therapy with saxagliptin/metformin XR versus glipizide XL for type 2 diabetes with sev…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Michigan Men's Diabetes Project [NA]
A completed clinical trial conducted by the University of Michigan in Type 2 diabetes; results have been posted.
-
FDA approval · 2023-06-20FDA Approved: SYNJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SYNJARDY XR (empagliflozin/metformin hydrochloride) by Boehringer Ingelheim Pharmaceuticals,…
-
FDA approval · 2023-06-20FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
FDA approval · 2023-06-20FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2023-06-20FDA Approved: JENTADUETO XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for JENTADUETO XR (linagliptin and metformin hydrochloride) by Boehringer Ingelheim Pharmaceuticals,…
-
FDA approval · 2023-06-20FDA Approved: TRADJENTA — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Tradjenta (linagliptin) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2023-06-20FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (VGYAAN Pharmaceuticals LLC)
The FDA approved an original application for metformin hydrochloride, a generic form of metformin, manufactured by VGYAAN Pharmaceuticals LL…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) [Phase 3]
Phase 3 trial update for metformin/atorvastatin combination therapy in adults with Type 2 diabetes and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Ursodeoxycholic Acid as add-on Therapy in Type 2 Diabetes Mellitus [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating ursodeoxycholic acid as add-on therapy for type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Motivational Interviewing (MI) Intervention to Improve Adherence [NA]
Clinical trial on Motivational Interviewing to improve adherence in adults with type 2 diabetes and hypertension has completed with posted r…
-
CLINICAL_TRIALS research · 2023-06-13Clinical Trial Update: Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD [Phase 4]
A Phase 4 trial comparing adding vildagliptin versus glimepiride to metformin in type 2 diabetes patients with coronary artery disease, focu…